Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

NCT01129557 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Proteinuric Kidney Disease
Diabetic Nephropathy
Hypertensive Nephrosclerosis
IgA Nephropathy
Focal Segmental Glomerulosclerosis
Glomerulopathy (Obesity-associated)
Glomerulonephritis, Membranous

Interventions

DRUG: Aliskiren
DRUG: Valsartan

Sponsor

Columbia University

Collaborators

[object Object]